Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo- controlled, 12-week study in early postmenopausal women.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples